Open AccessThe role of docetaxel in the multimodal treatment of non-small cell lung cancer
Author(s) -
Rita De Sanctis,
I. D’Antoni,
Ester Del Signore,
Bruno Gori,
Flavia Longo
Publication year - 2009
Publication title -
clinical management issues
Language(s) - English
Resource type - Journals
eISSN - 2283-3137
pISSN - 1973-4832
DOI - 10.7175/cmi.v3i2.550
Subject(s) - docetaxel , medicine , radiation therapy , cisplatin , chemotherapy , lung cancer , oncology , quality of life (healthcare) , cancer , lung , multimodal therapy , nursing
We report the case of a 53-year-old woman with brain metastatic Non-Small Cell Lung Cancer (NSCLC). Diagnosis was made during brain surgery. Brain metastases were treated both with surgery and radiotherapy. The chemotherapy schedule was cisplatin 75 mg/m2 and docetaxel 75 mg/m2 1q21 for up to six cycles. Toxicities encountered were easily manageable. Subsequent thoracic radiotherapy improved tumor response and quality of life